Cardiovascular Effects of EVOO in Healthy Reproductive-aged Women

Status unconfirmed · Not applicable

Conditions studied: Hypertension, Vascular Stiffness

In brief

This study aims to compare changes in cardiovascular function and markers of inflammation and metabolic dysfunction in women randomized to treatment with extra virgin olive oil (EVOO) versus those randomized to treatment with a control oil low in oleic acid and phenols for 8 weeks.

Key facts

Study ID

NCT03820336

Run by

University of Vermont Medical Center

People needed

40

Starts

2019-02-01

Expected to finish

2020-02-01

Last updated by the study team

2019-04-17

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women are eligible to participate if they are between the ages of 18 and 40, in good health, with regular menstrual cycles and no prior pregnancies.

You may not qualify if…

• Routinely take medications or supplements known to affect blood pressure, heart or blood vessel function, or those with anti-inflammatory or antioxidant properties
• Smoking
• Pregnancy
• Other conditions that would impair adherence, such as allergy to olive oil or sunflower oil or difficulty swallowing

Where it is running

• University of Vermont Medical Center — Burlington, Vermont, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.